鈞達股份(002865.SZ):基於目前的產能規劃,2024年的產能規模不低於2023年
格隆匯5月29日丨鈞達股份(002865.SZ)於2023年5月26日下午14:30-17:00召開業績説明會,問答環節中,就“公司2024年的產能規模大概在多少?”,公司回覆稱,截止目前滁州基地18GW的N型topcon產能已滿產;淮安基地一期13GW的N型topcon產能已投產(爬坡中),二期13GW的N型topcon產能正建設中,預計2023年實現滿產。到2023年底,公司光伏電池的總產能將達53.5GW,其中N型topcon產能將達44GW。基於目前的產能規劃,2024年的產能規模不低於2023年。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.